Supporting that, CD93 overexpression was found in tumor vasculatures, and it influenced the survival of the host in PDAC, PNET, melanoma, and colon cancer (Langenkamp et al., 2015; Olsen et al., 2015; Sun et al., 2021). Here, CD93 is linked to colonic neoplasm.